Presented
by

Presented by Oxford Global

Discover PLUS Pass
Industry Spotlight  |
Biomarkers for Clinical Development

In Conversation With… Shuang Liang, Assistant Professor at UT Southwestern Medical Centre

Edited by Ben Norris |
17 November 2023
Here, we speak to UT Southwestern’s Shuang Liang about monitoring TREM2 as a non-invasive diagnostic biomarker for NASH.

Get your regular dose of industry news and announcements here, and keep up to date with the latest ‘Industry Spotlight’ posts. 

Visit our Biomarkers Portal to learn more about the latest research into spatial omics and its developments. If you’d like to register your interest for Oxford Global‘s upcoming Biomarkers UK conference, click here to download an agenda or register your interest.

How would you rate this content?

Share this article

Sign up for our monthly Biomarkers Newsletter

> Register

You may also be interested in...

Matthias von Herrath
Video Q&A
Advancing Biomarkers and Diagnostics in Diabetes Clinical Trials
Here, we speak to Matthias von Herrath about Biomarkers US 2023 and some current trends in the industry concerning research and technological development.
20 November 2023
Noninvasive Blood Tests for the Diagnosis of Liver Disease
Industry Spotlight
Non-Invasive Blood Tests for the Diagnosis of Liver Disease 
A recent FNIH study demonstrates the effectiveness of non-invasive blood tests in diagnosing non-alcoholic steatohepatitis (NASH), potentially reducing the need for invasive liver biopsies and improving NASH diagnosis.
07 November 2023

Continue browsing

> All Biomarkers Content

Share this article

Join our Biomarkers mailing list

> Register

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Biomarkers

> Register